We are live on ! Find out more
PHIO icon

Phio Pharmaceuticals
PHIO

1 hedge funds and large institutions have $2.98M invested in Phio Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

15% less capital invested

Capital invested by funds: $3.51M → $2.98M (-$529K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$100K
2
Jane Street
Jane Street
New York
-$56K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$28K
4
PP
Paloma Partners
Connecticut
-$25K
5
Group One Trading
Group One Trading
Illinois
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadfin Capital
New York
$1.8M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$339K – – –
TAM
3
Tocqueville Asset Management
New York
$200K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$133K – – –
CS
5
Credit Suisse
Switzerland
$129K – – –
VKH
6
Virtu KCG Holdings
New York
$67K – – –
Morgan Stanley
7
Morgan Stanley
New York
$58K – – –
SIM
8
Spark Investment Management
New York
$57K – – –
BW
9
Bison Wealth
Georgia
$48K – – –
Goldman Sachs
10
Goldman Sachs
New York
$41K – – –
Northern Trust
11
Northern Trust
Illinois
$25K – – –
Bank of America
12
Bank of America
North Carolina
$22K – – –
Citadel Advisors
13
Citadel Advisors
Florida
$19K – – –
ARTA
14
A.R.T. Advisors
New York
$18K – – –
Deutsche Bank
15
Deutsche Bank
Germany
$8K – – –
TRCT
16
Tower Research Capital (TRC)
New York
$5K – – –
BIM
17
BlackRock Investment Management
Delaware
$4K – – –
LTFS
18
Ladenburg Thalmann Financial Services
Florida
$1K – – –
AIG
19
American International Group
New York
– -$22 – –
Group One Trading
20
Group One Trading
Illinois
– -$5K – –
Jane Street
21
Jane Street
New York
– -$56K – –
PP
22
Paloma Partners
Connecticut
– -$25K – –
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
– -$28K – –
TCM
24
Tang Capital Management
California
– -$100K – –

PHIO Hedge Fund Activity: Q4 2014 in Review

1 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals (PHIO) for Q4 2014, worth a combined $2.98M — down 15% from $3.51M a quarter earlier.

Fund positioning in PHIO was balanced in Q4 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Tang Capital Management, cutting an estimated $100K.

  • 1 institutional investor held Phio Pharmaceuticals (PHIO) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $2.98M of Phio Pharmaceuticals stock for Q4 2014, down 15% quarter-over-quarter.
  • 0 funds opened new Phio Pharmaceuticals positions in Q4 2014 and 0 closed out.
  • The largest Phio Pharmaceuticals seller in Q4 2014 was Tang Capital Management, an estimated $100K sold.

Based on aggregated 13F filings for Q4 2014.